- Home
- CPAY vs WAT Comparison
CPAY vs WAT Comparison
Compare CPAY & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- WAT
- Stock Information
- Founded
- CPAY 1986
- WAT 1958
- Country
- CPAY United States
- WAT United States
- Employees
- CPAY N/A
- WAT N/A
- Industry
- CPAY EDP Services
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- CPAY Technology
- WAT Industrials
- Exchange
- CPAY Nasdaq
- WAT Nasdaq
- Market Cap
- CPAY 24.1B
- WAT 22.5B
- IPO Year
- CPAY 2010
- WAT 1995
- Fundamental
- Price
- CPAY $374.34
- WAT $387.29
- Analyst Decision
- CPAY Buy
- WAT Hold
- Analyst Count
- CPAY 12
- WAT 13
- Target Price
- CPAY $376.73
- WAT $363.92
- AVG Volume (30 Days)
- CPAY 523.1K
- WAT 531.3K
- Earning Date
- CPAY 11-07-2024
- WAT 11-01-2024
- Dividend Yield
- CPAY N/A
- WAT N/A
- EPS Growth
- CPAY 9.84
- WAT N/A
- EPS
- CPAY 14.01
- WAT 10.48
- Revenue
- CPAY $3,877,478,000.00
- WAT $2,905,147,000.00
- Revenue This Year
- CPAY $8.44
- WAT $0.53
- Revenue Next Year
- CPAY $11.88
- WAT $5.59
- P/E Ratio
- CPAY $26.68
- WAT $36.79
- Revenue Growth
- CPAY 4.68
- WAT N/A
- 52 Week Low
- CPAY $247.10
- WAT $279.24
- 52 Week High
- CPAY $385.30
- WAT $395.44
- Technical
- Relative Strength Index (RSI)
- CPAY 60.86
- WAT 61.58
- Support Level
- CPAY $376.60
- WAT $380.14
- Resistance Level
- CPAY $384.80
- WAT $395.44
- Average True Range (ATR)
- CPAY 6.77
- WAT 10.45
- MACD
- CPAY -0.36
- WAT 1.15
- Stochastic Oscillator
- CPAY 60.48
- WAT 85.13
About CPAY Corpay Inc.
Corpay Inc is a global S&P500 corporate payments company that helps businesses and consumers pay expenses in a simple, controlled manner. Its suite of modern payment solutions helps its customers better manage vehicle-related expenses (such as fueling and parking), travel expenses (e.g. hotel bookings), and payables (e.g. paying vendors). This results in its customers saving time and ultimately spending less.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.